Dinoksilin je sintetičko jedinjenje koje je razvijeno za primenu u naučnim istraživanjima. Dinoksilin deluje kao potentanpun agonist na svih pet podtipovadopaminskog receptora.[3][4][5]
↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Grubbs RA, Lewis MM, Owens-Vance C, Gay EA, Jassen AK, Mailman RB, Nichols DE (March 2004). „8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms”. Bioorganic & Medicinal Chemistry12 (6): 1403–12. DOI:10.1016/j.bmc.2004.01.008. PMID15018913.
↑Ryman-Rasmussen JP, Nichols DE, Mailman RB (October 2005). „Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists”. Molecular Pharmacology68 (4): 1039–48. DOI:10.1124/mol.105.012153. PMID15985612.
↑Zhang J, Xiong B, Zhen X, Zhang A (March 2009). „Dopamine D1 receptor ligands: where are we now and where are we going”. Medicinal Research Reviews29 (2): 272–94. DOI:10.1002/med.20130. PMID18642350.